Cas:32785-40-3 Pyrimidine, 2-chloro-4-methyl-6-phenyl- manufacturer & supplier

Chemical Name:Pyrimidine, 2-chloro-4-methyl-6-phenyl-

CAS.NO:32785-40-3

Synonyms:2-chloro-4-phenyl-6-methylpyrimidine;2-chloro-4-methyl-6-phenyl-pyrimidine;Pyrimidine,2-chloro-4-methyl-6-phenyl;2-Chlor-4-methyl-6-phenyl-pyrimidin;Pyrimidine, 2-chloro-4-methyl-6-phenyl-

Molecular Formula:C₁₁H₉ClN₂

Molecular Weight:204.65600

HS Code:2933599090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:25.78000

Exact Mass:204.04500

LogP:3.10540

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-chloro-4-phenyl-6-methylpyrimidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyrimidine, 2-chloro-4-methyl-6-phenyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-chloro-4-phenyl-6-methylpyrimidine Use and application,2-chloro-4-methyl-6-phenyl-pyrimidine technical grade,usp/ep/jp grade.

Related News: Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. Pyrimidine, 2-chloro-4-methyl-6-phenyl- manufacturer Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. Pyrimidine, 2-chloro-4-methyl-6-phenyl- supplier ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.�� Pyrimidine, 2-chloro-4-methyl-6-phenyl- vendor Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. Pyrimidine, 2-chloro-4-methyl-6-phenyl- factory Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms.